Search Results
Nov 07, 2025, 06:41 ET AION UT Officially Launched in Macao, GAC Deeply Implements 'Macao ACTION' to Accelerate Ecological Globalization
comfortable riding space comparable to that of luxury sedans, and believed that the rich technological configurations such as intelligent voice interaction and L2-level advanced driver assistance system exceeded expectations. Macao's professional automobile media stated that the AION UT performs outstandingly in
More news about: GAC
Nov 07, 2025, 06:23 ET AION UT Officially Launched in Macao, GAC Deeply Implements 'Macao ACTION' to Accelerate Ecological Globalization
comfortable riding space comparable to that of luxury sedans, and believed that the rich technological configurations such as intelligent voice interaction and L2-level advanced driver assistance system exceeded expectations. Macao's professional automobile media stated that the AION UT performs outstandingly in
More news about: GAC
Nov 07, 2025, 04:30 ET LEPAS Elegant Technology Safeguards Every Elegant Journey with Global Five-Star Safety Standards
seasons, the LEPAS L8 is engineered with a wading depth over 600 mm for secure passage through water-logged roads. Rollover scenarios—responsible for 20% of single-vehicle accidents—also undergo comprehensive validation. At the 2025 Chery International User Summit, the flagship LEPAS L8 completed underbody-scrape,
More news about: Chery Group
Nov 07, 2025, 04:01 ET LEPAS優雅科技以全球五星安全標準，守護每一段優雅旅程
優雅科技的安全設計更深度貼合全球用戶的真實生活場景。通過事故調查發現，車速30-70km/h時車輛刮底損壞概率更高，品牌針對性優化底盤防護；針對東南亞長期多雨環境，LEPAS L8全系按涉水深度>600mm開發，從容應對積水路段；面對占單車事故20%、乘員受傷率高15%-20%的翻滾工況，更是進行全方面驗證。在2025奇瑞國際用戶生態大會首次公開的安全實驗上，品牌旗下旗艦車型LEPAS L8，以出色的表現完成了刮底、涉水、碰撞翻滾三大嚴苛測試，完美詮釋了LEPAS在安全領域的硬核實力。此外，多項主動安全功能與泊車輔助系統，讓「優雅駕控」全程可控。 為實現這一嚴苛安全目標，優雅科技依托奇瑞集團涵蓋全球各個國家和地區的最高開發標準，在集團覆蓋全人員、全過程、全工況、全方位、全市場的全維安全防護體系框架之下，致力於為全球用戶提供全方位的安全保障。
More news about: 奇瑞集團
Nov 07, 2025, 03:47 ET LEPAS Elegant Technology Safeguards Every Elegant Journey with Global Five-Star Safety Standards
seasons, the LEPAS L8 is engineered with a wading depth over 600 mm for secure passage through water-logged roads. Rollover scenarios—responsible for 20% of single-vehicle accidents—also undergo comprehensive validation. At the 2025 Chery International User Summit, the flagship LEPAS L8 completed underbody-scrape,
More news about: Chery Group
Nov 07, 2025, 02:40 ET TAILG, 3년 연속으로 밀라노에서 별이 되다...글로벌 전기 모빌리티의 신흥 강자로 우뚝
TAILG는 글로벌 저탄소 모빌리티 연구소(Global Low-Carbon Mobility Research Institute)의 지원 속에 나트륨 이온 배터리, 수소 에너지, 고속 충전 및 자율 주행 분야에서 전진을 계속하고 있다.이번 전시회에서 F73L 자율 주행 데모는 정밀도와 제어력으로 보는 이에게 깊은 인상을 남겼다. TAILG는 또 개방형 혁신을 받아들여 IoT 차량 연결과 관련해서는 화웨이와, 주행 거리와 안전성을 높여 주는 첨단 배터리 시스템과 관련해서는 BYD와 파트너십을
More news about: TAILG
Nov 07, 2025, 02:00 ET Lunai Bioworks réussit à éliminer complètement les tumeurs pancréatiques primaires et secondaires dans des modèles humanisés précliniques, marquant une avancée significative pour l'immunothérapie allogénique contre le cancer
la première fois une puissante activité antitumorale des CD34+ dérivées de cellules souches hématopoïétiques (CSH) et modifiées pour surexprimer les CD40L, CD93 et CXCL13 dans des modèles murins humanisés de cancer du pancréas. Alors que l'étude initiale utilisait un vecteur lentiviral de qualité recherche,
More news about: Lunai Bioworks Inc.
Nov 07, 2025, 02:00 ET Lunai Bioworks logra la regresión completa de tumores pancreáticos primarios y metastásicos
actividad antitumoral de las células dendríticas (DC) derivadas de células madre hematopoyéticas (HSC) CD34+, modificadas genéticamente para sobreexpresar CD40L, CD93 y CXCL13 en modelos de ratón humanizados de cáncer de páncreas. Si bien el estudio inicial utilizó un vector lentiviral de grado de investigación,
More news about: Lunai Bioworks Inc.
Nov 07, 2025, 01:47 ET ミラノで3年連続の輝きを放つ TAILG、世界の電動モビリティに新たな波をリード
グローバル低炭素モビリティ研究所の支援を受け、TAILG はナトリウムイオン電池、水素エネルギー、急速充電、自動運転の分野で前進しています。 展示会では、F73L の自律走行デモがその精密さと制御力で観客を魅了しました。 TAILG はオープンイノベーションも推進しており、Huawei と IoT 車両接続で提携し、BYD と先進バッテリーシステムで協力して航続距離と安全性を向上させています。
More news about: TAILG
Nov 07, 2025, 01:00 ET Harbour BioMed and Evinova China Announce Strategic AI Collaboration to Accelerate AI-Enabled Drug Development
antibody technology platform, Harbour Mice®, generates fully human monoclonal antibodies in both the conventional two heavy and two light chain (H2L2) format and the heavy chain-only (HCAb) format. Building upon HCAb antibodies, the HCAb-based immune cell engagers (HBICE®) bispecific antibody
More news about: Harbour BioMed
Nov 06, 2025, 21:22 ET 世界初の APOC3 を標的とした高脂血症向け遺伝子編集治療薬
ける両アレル突然変異によって引き起こされる稀な常染色体劣性疾患であり、空腹時トリグリセリド（TG）が10 mmol/L（885 mg/dL）以上、世界的な有病率は10万人に1人〜100万人に1人とされています。MCSは、遺伝的要因、生活習慣、または代謝性疾患の複雑な相互作用によって発症し、世界的な有病率は最大で600人に1人とされています。 現在のカイロミクロン血症の治療は主に、急性膵炎のリスク閾値（<5.7 mmol/L または 500 mg/dL）未満に空腹時トリグリセリド（TG）値を管理することを目的としています。しかし、既存のトリグリセリド低下薬では十分な効果が得られないことが多く、また超低脂肪食は長期的な継続が困難です。
More news about: CorrectSequence Therapeutics
Nov 06, 2025, 20:30 ET La Fundación Michael J. Fox para la Investigación sobre Parkinson celebra a los votantes de Texas por la aprobación de la Proposición 14 que asegura $3 mil millones para la investigación de enfermedades cerebrales
seres queridos que también enfrentan esta enfermedad, he visto lo poderoso que es cuando nuestra comunidad se une para impulsar el cambio", señaló María L. De León, doctora en medicina, residente del este de Texas, especialista en trastornos del movimiento y miembro del Consejo de Pacientes de la MJFF. "La
More news about: The Michael J. Fox Foundation for Parkinson's Research
Nov 06, 2025, 20:00 ET 復星國際榮獲《財資》雜誌頒發的「2025年財資企業永續領導獎金獎」及「最佳可持續發展團隊獎」
全球首個獲批用於一線治療小細胞肺癌的抗PD-1單抗。截至目前，H藥已在中國、歐盟、英國、新加坡、印度等近40個國家和地區獲批上市，惠及全球逾11萬名患者。 今年以來，復星在創新藥領域實現多點破局。HLX43是一款靶向PD-L1的抗體偶聯藥物（ADC），正在中、美、日、澳等國家開展非小細胞肺癌、胸腺癌等實體瘤的臨床研究。目前，全球範圍內尚無PD-L1 ADC獲批上市，HLX43有潛力成為高效、安全的「廣譜抗癌藥」。此外，在小分子創新藥方面，復星自研的靶向藥物復邁寧獲批兩項罕見病適應症，填補了相關罕見病腫瘤領域的治療空白。
More news about: 復星
Nov 06, 2025, 20:00 ET Fosun International Honored with Gold Award and Best Sustainability Team at The Asset Corporate Sustainability Leadership Awards 2025
of innovative drugs. HLX43, a PD-L1-targeting antibody-drug conjugate (ADC) is undergoing clinical studies for solid tumors such as non-small cell lung cancer and thymic carcinoma in countries including China, the United States, Japan, and Australia. Currently, no PD-L1 ADC has been approved globally,
More news about: Fosun
Nov 06, 2025, 19:10 ET ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes International Debut
CS2015 lead molecule demonstrated potent inhibition of OX40L/OX40 and TSLP/TSLPR downstream signaling: CS2015 potently interrupted the engagement of hOX40L on hOX40 reporter cells and hTSLP on hTSLPR/IL-7Rα reporter cells, respectively;
More news about: CStone Pharmaceuticals
Nov 06, 2025, 19:00 ET 里程碑突破！全球首個APOC3基因編輯臨床治療高血脂獲得成功
Syndrome，MCS）。其中FCS是一種罕見的常染色體隱性遺傳病，由於脂蛋白脂肪酶（Lipoprotein lipase，LPL）基因或參與調控LPL活性的關鍵基因發生雙等位基因突變，導致脂蛋白脂肪酶功能受損，使甘油三脂的分解代謝產生障礙，從而造成體內乳糜微粒的蓄積，通常患者的空腹TG水準≥10 mmol/L (885 mg/dL)，全球發病率在十萬分之一到百萬分之一之間；而MCS則由多種因素引起的病理狀態，其發病受遺傳背景、生活習慣或其他代謝疾病共同影響，全球發病率高達1/600。 目前，高乳糜微粒血症的主要治療策略是將患者的空腹甘油三脂（TG）水準控制在急性胰腺炎風險閾值以下（通常需<5.7
More news about: CorrectSequence Therapeutics
Nov 06, 2025, 18:52 ET Lunai Bioworks 在臨床前人源化模型內，實現原發性和轉移性胰臟腫瘤的完全消退，標誌為同種異體癌症免疫療法的突破
的療法利用基因工程改造的樹突狀細胞（幹細胞創造的特殊免疫細胞），這些細胞經過基因增強而啟動人體免疫系統來抗癌。該刊登詳細介紹該平台的第二代臨床合規版本，並提供推進該療法持續合作對話的關鍵證據。 這項新發表建基於 Lunai 的較早研究（Vaccines 2025 Jul 12;13(7):749; doi:10.3390/vaccines13070749），該研究首次在人源化胰腺癌小鼠體內證明，經過基因改造過度表達 CD40L、CD93 和 CXCL13 的 CD34+ 造血幹細胞 (HSC) 衍生的樹突狀細胞 (DC) 具備強大抗腫瘤活性。雖然最初研究採用研究級慢病毒載體，但最新報告描述一種最佳化兼符合臨床規範的構建體。該構建體保持同等療效，同時改進設計與製造特性，從而支持未來臨床轉化。
More news about: Lunai Bioworks Inc.
Nov 06, 2025, 18:00 ET Aily Labs Raises $80 Million to Scale AI that Drives Performance across Fortune 500 Companies
extract real business value from it. That's what compelled us to invest in Aily Labs – their platform delivers actionable insights that drive measurable P&L impact," said Pegah Ebrahimi, Co-founder & Managing Partner at FPV Ventures. "CEOs tell us they're making different decisions because of
More news about: Aily Labs
Nov 06, 2025, 18:00 ET Aily Labs Raises $80 Million to Scale AI that Drives Performance across Fortune 500 Companies
extract real business value from it. That's what compelled us to invest in Aily Labs – their platform delivers actionable insights that drive measurable P&L impact," said Pegah Ebrahimi, Co-founder & Managing Partner at FPV Ventures. "CEOs tell us they're making different decisions because of
More news about: Aily Labs
Nov 06, 2025, 18:00 ET ATD Saudi Arabia 2025: Shaping the Future-Ready Workforce for Vision 2030
transformation into lasting growth." Since its inception, ATD Saudi Arabia Conference has evolved into a cornerstone of the Kingdom's L&D landscape, serving as a catalyst for change and a bridge between global best practices and regional innovation. Over the years, it has hosted some
More news about: Association for Talent Development (ATD)
Nov 06, 2025, 16:15 ET MAIN STREET ANNOUNCES THIRD QUARTER 2025 RESULTS
"August 2028 Notes") In commenting on the Company's operating results for the third quarter of 2025, Dwayne L. Hyzak, Main Street's Chief Executive Officer, stated, "We are pleased with our performance in the third quarter, which resulted in another quarter of
More news about: Main Street Capital Corporation
Nov 06, 2025, 16:05 ET FLOWERS FOODS, INC. REPORTS THIRD QUARTER 2025 RESULTS
partially offset, inflationary pressure or tariffs (including retaliatory tariffs) on the cost of our products, including ingredient and packaging costs; (l) disruptions in our direct-store-delivery distribution model, including litigation or an adverse ruling by a court or regulatory or governmental body
More news about: Flowers Foods, Inc.
Nov 06, 2025, 15:56 ET ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Golden Entertainment, Inc.
securities law violations by Golden Entertainment, Inc. (NASDAQ: GDEN) and its board of directors concerning the proposed acquisition of the company by Blake L. Sartini and VICI Properties Inc. (NYSE: VICI). Stockholders will receive $2.75 in cash and 0.902 shares of VICI Properties common stock for each share
More news about: Rowley Law PLLC
Nov 06, 2025, 15:46 ET Halper Sadeh LLC Encourages BHF, GDEN, FRGE Shareholders to Contact the Firm to Discuss Their Rights
Golden Entertainment, Inc.'s (NASDAQ: GDEN)'s sale of its operating assets to Blake L. Sartini and affiliates, and seven of its casino real estate assets to VICI Properties Inc. Under the terms of the proposed transaction,
More news about: Halper Sadeh LLP
Nov 06, 2025, 15:20 ET Monroe University's Mustangs Athletic Program Joins Central Atlantic Collegiate Conference
energy, talent, and commitment Monroe's student-athletes will bring as we continue to elevate the experience for all teams in our conference," said John L. Hopkins, Chair of the CACC Presidents Council and President and CEO of Post University. "I join my fellow administrators throughout
More news about: Monroe University